slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 64,501-64,530
Pages 2,605
Rows per page 30
Component
64,501-64,530 of 78,138
21
Uses a bridge-style visualization to show the net impact of cost changes.Hugo Boss | Investor Presentation Deck | 104 slides · Hugo Boss
Conference presentation Investor relations Beat · Market Size1 hit
23
The chart shows a spike in 2020 followed by a decline, with a target range of 16-18% for the 2023-2025 period.Hugo Boss | Investor Presentation Deck | 104 slides · Hugo Boss
Conference presentation Investor relations Beat · Market Size1 hit
42
The slide uses a three-column layout to map product categories to strategic business objectives.Hugo Boss | Investor Presentation Deck | 104 slides · Hugo Boss
Conference presentation Investor relations Beat · Financials1 hit
56
The slide uses a split-layout design with a photo on the left and quantitative metrics on the right and bottom.Hugo Boss | Investor Presentation Deck | 104 slides · Hugo Boss
Conference presentation Investor relations Beat · Financials1 hit
59
The background features a world map, emphasizing the global nature of the franchise expansion strategy.Hugo Boss | Investor Presentation Deck | 104 slides · Hugo Boss
Conference presentation Investor relations Beat · Financials1 hit
87
The chart uses a dual-axis approach: bars for absolute EUR million values and a trend line for percentage of sales.Hugo Boss | Investor Presentation Deck | 104 slides · Hugo Boss
Conference presentation Investor relations 1 hit
16
The chart shows revenue in millions. 2023 is a projected range.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations 1 hit
17
The chart is a waterfall-style progression showing margin improvement.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations 1 hit
18
The slide uses a bar chart to visualize the reduction in cash burn and a callout box for the current cash position.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations 1 hit
17
The 2023 data point is a guidance range of $11M-$13M.Hyperfine | Investor Presentation Deck | 24 slides · Hyperfine
Conference presentation Investor relations 1 hit
18
The chart is a waterfall-style progression showing margin improvement.Hyperfine | Investor Presentation Deck | 24 slides · Hyperfine
Conference presentation Investor relations 1 hit
19
The slide uses a bar chart to show a reduction in cash burn and a callout for total cash on hand.Hyperfine | Investor Presentation Deck | 24 slides · Hyperfine
Conference presentation Investor relations 1 hit
09
The chart uses a semi-circular 'onion' or 'layer' diagram to represent market segments, with a legend on the right detailing specific applications for each layer.Hyzon | Results Presentation Deck | 15 slides · Hyzon
Conference presentation Investor relations Beat · Market Size1 hit
12
The chart shows revenue growth for cohorts starting in FY19-FY23, with Year 2 and Year 3 data for recent cohorts being estimates.IBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · Rising Success1 hit
13
The chart uses a trend arrow to emphasize the CAGR.IBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · The Breakthrough1 hit
05
The chart shows revenue performance for cohorts starting in FY19-FY23, with Year 2 and Year 3 data points for recent cohorts being estimates.IBEX | Results Presentation Deck | 25 slides · ibex
Conference presentation Investor relations Beat · Need1 hit
06
The chart highlights a 68% CAGR for BPO 2.0 clients.IBEX | Results Presentation Deck | 25 slides · ibex
Conference presentation Investor relations Beat · Need1 hit
11
The slide uses a bar chart to show year-over-year growth in Adjusted EBITDA and lists key operational drivers.IBEX | Results Presentation Deck | 25 slides · ibex
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
07
The slide uses a Gantt-style visualization to show the progress of various drug candidates across different clinical phases.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Solution1 hit
15
Includes clinical trial screening data for specific cancer types.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
34
Uses a ridge plot (joyplot) to visualize distribution of PRAME expression across 7 cancer types.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
47
The chart shows a clear performance advantage for the blue line (TCER®) over the grey lines.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
48
The chart uses a broken axis to show early time points and late-stage tumor volume divergence.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
49
The slide uses a 3x4 grid of line charts to demonstrate the safety profile of the proprietary TCER format.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
51
Includes ISH images, a prevalence table, and a dot plot comparing peptide density.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
53
The slide illustrates the methodology for PK analysis (injection, sampling, quantification) and presents the resulting concentration-time curve.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
56
The chart uses a broken x-axis between -29 and 0. The legend indicates four distinct treatment groups.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
57
The slide uses a log-linear plot to demonstrate drug clearance over time.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
62
The chart is a dot plot showing quantitative target density (CpC) for two different peptide targets.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
08
The slide uses a structural diagram to highlight the specific modifications (COBRA Binder) that differentiate NXC-201 from the reference therapy.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit